Related Experiment Video
Updated: Jun 18, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
Regulation of antiviral immunity by PD-1 during respiratory syncitial virus infection and upon vaccination
Linmar Rodríguez-Guilarte1,2,3, Constanza Méndez1,2, M Fernanda Rojas1,2
1Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.
Abstract:
Respiratory syncytial virus (RSV) induces a protective immune response shaped by regulatory pathways that control T cell function. The inhibitory receptor PD-1 is a central modulator of these processes. Here, we analyzed PD-1, LAG-3, and TIM-3 expression in CD8+ T cells during RSV infection and evaluated PD-1/PD-L1 modulation across different immunological contexts in mice. PD-1 expression progressively increased in lung CD8+ T cells at 5- and 9-day post-infection, accompanied by co-expression of LAG-3 and TIM-3, and elevated PD-L1 in epithelial and antigen-presenting cells. PD-1 modulation varied with context: passive immunization reduced its expression, whereas rBCG-N-RSV vaccination followed by infection increased PD-1 and cytokine production. PD-1 blockade enhanced memory T cell generation and the quality of the humoral response, whereas PD-1 deficiency impaired these responses. These findings support a context-dependent role for PD-1 in coordinating antiviral immunity and vaccine-induced immune responses.
More Related Videos
Related Concept Videos
Respiratory Syncytial Virus Disease
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Inhibitors of Viral Protein Synthesis
Vaccinations
Vaccines
Chickenpox

